Seres Therapeutics Inc
Change company Symbol lookup
Select an option...
MCRB Seres Therapeutics Inc
TC TuanChe Ltd
ENSG Ensign Group Inc
INO Inovio Pharmaceuticals Inc
WHR Whirlpool Corp
TTOO T2 Biosystems Inc
AAPL Apple Inc
HOKCY Hong Kong and China Gas Co Ltd
NWFFX American Funds New World Fund® Class F-1

Health Care : Biotechnology | Small Cap Growth
Company profile

Seres Therapeutics, Inc. is a microbiome therapeutics platform company. The Company is engaged in developing a class of biological drugs, which is referred as Ecobiotic microbiome therapeutics. The Company's drugs are designed to restore health by repairing the function of a dysbiotic microbiome. The Company is focused on implementing its microbiome therapeutics platform to develop Ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. SER-109 is its lead product candidate, which is designed to prevent further recurrences of Clostridium difficile infection (CDI). The Company is developing additional product candidates, including SER-262 to prevent an initial recurrence of primary CDI; SER-287 and SER-301, to treat inflammatory bowel disease (IBD), including ulcerative colitis, and SER-155 to treat enteric bacterial pathogens.

Closing Price
Day's Change
-1.21 (-4.50%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:

KBRA Assigns B+ Issuer Rating to Hawaiian Holdings Inc. and Hawaiian Airlines Inc. and A and BBB Preliminary Ratings to HA 2020-1 Class A and B Enhanced Equipment Trust Certificates (EETC)

5:24 pm ET July 28, 2020 (BusinessWire) Print

Kroll Bond Rating Agency (KBRA) assigns issuer ratings of B+ with a Negative Outlook to Hawaiian Holdings, Inc. and its direct wholly owned subsidiary, Hawaiian Airlines, Inc. (collectively "Hawaiian" or "HA"). KBRA also assigns an A rating to Hawaiian's proposed pass-through trust series 2020-1 $217.0 million Class A certificates due September 2027 and BBB to $45.0 million Class B certificates due September 2025, with a Negative Outlook.

The credit ratings for Hawaiian reflect our expectation that the company has sufficient level of liquidity to manage through the COVID-19 crisis. HA entered the crisis from a strong liquidity position and with modest level of near-term debt maturities. The company has taken aggressive steps to preserve liquidity by suspending dividends and share repurchase programs, deferring non-aircraft capex, delaying payments to suppliers and deferring maintenance on aircraft. The ratings are further supported by the company's strong position in the Hawaiian interisland travel market, demonstrated track record of stable operating performance and recent fleet renewal. Credit negatives include company's geographic concentration and its reliance on demand for leisure travel to the Hawaiian Islands. The company's small size, unionized workforce and diminishing access to external capital compared to its much larger U.S. peers are additional limiting factors. The Negative Outlook primarily reflects our expectations for slower recovery in demand such that HA's credit metrics will be outside its historic levels for the next 18-24 months.

The preliminary A and BBB ratings for Class A and Class B Certificates, respectively, reflect KBRA's expected loss simulation, the issuer rating of Hawaiian Airlines, Inc., the legal protection provided under Section 1110 of the U.S. Bankruptcy Code ("Section 1110") and the underlying good-quality aircraft collateral pool as well as the pool's significant importance to HA's operations, which support a high likelihood of affirmation in the case of bankruptcy or restructuring of HA. The ratings also take into account the priority of payments for the senior and subordinated certificates, the payment-in-kind ("PIK") feature of up to three semi-annual interest payments (which have been put in place in lieu of a liquidity facility) and the other EETC structural protections available to the certificate holders. The Negative Outlook captures the current uncertainty of aircraft values and weak secondary market demand.

Click here to view the report on Hawaiian Airlines and click here to view the report on HA 2020-1 Class A and B Certificates. To access ratings and relevant documents, click here.

Related Publications

Coronavirus (COVID-19): Aircraft Values and Lease Rates Coronavirus (COVID-19): Air Cargo: A Bright Spot in a Dark Sky


Further information on key credit considerations, sensitivity analyses that consider what factors can affect these credit ratings and how they could lead to an upgrade or a downgrade, and ESG factors (where they are a key driver behind the change to the credit rating or rating outlook) can be found in the full rating report referenced above.

A description of all substantially material sources that were used to prepare the credit rating and information on the methodology(ies) (inclusive of any material models and sensitivity analyses of the relevant key rating assumptions, as applicable) used in determining the credit rating is available in the U.S. Information Disclosure Form located here and here.

Information on the meaning of each rating category can be located here.

Further disclosures relating to this rating action are available in the U.S. Information Disclosure Form referenced above. Additional information regarding KBRA policies, methodologies, rating scales and disclosures are available at

About KBRA

KBRA is a full-service credit rating agency registered as an NRSRO with the U.S. Securities and Exchange Commission. In addition, KBRA is designated as a designated rating organization by the Ontario Securities Commission for issuers of asset-backed securities to file a short form prospectus or shelf prospectus. KBRA is also recognized by the National Association of Insurance Commissioners as a Credit Rating Provider and is a certified Credit Rating Agency (CRA) with the European Securities and Markets Authority (ESMA). Kroll Bond Rating Agency Europe is registered with ESMA as a CRA.

View source version on

SOURCE: Kroll Bond Rating Agency (KBRA)

Analytical Contacts 
Boris Alishayev, Senior Director (Lead Analyst)
+1 (646) 731-2484

Danise Chui, Managing Director
+1 (646) 731-2406

Sandy Azer, Associate Director
+1 (646) 731-1200

Marjan Riggi, Senior Managing Director (Rating Committee Chair)
+1 (646) 731-2354

Business Development Contact 
Nish Kumar, Senior Director
+1 (646) 731-3372
comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.